A pharmacoeconomic study of olopatadine hydrochloride 0.1% eye drops and bepotastine besilate 1.5% eye drops in the management of allergic conjunctivitis: A cost-effectiveness analysis

Background: Allergic conjunctivitis (AC) affects 10–20% of the Indian population, necessitating cost-effective treatment strategies. Aims and Objectives: We aimed to evaluate the comparison between the pharmacoeconomic profiles of olopatadine hydrochloride 0.1% and bepotastine besilate 1.5% eye d...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sudipto Chatterjee, Pritama Paul, Abhishek Bhattacharjee, Soumyadeep Mahapatra
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Manipal College of Medical Sciences, Pokhara 2026-03-01
coleção:	Asian Journal of Medical Sciences
Assuntos:	allergic conjunctivitis; cost-effectiveness analysis; olopatadine hydrochloride; bepotastine besilate; pharmacoeconomics; average cost-effectiveness ratio
Acesso em linha:	https://ajmsjournal.info/index.php/AJMS/article/view/5083
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!